Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants

EMBO Reports

Volumn 6, Issue 7, 2005, Pages 593-599

  Ma, Julian K C ^a   Barros, Eugenia ^b   Bock, Ralph ^c   Christou, Paul ^d   Dale, Philip J ^e   Dix, Philip J ^f   Fischer, Rainer ^g,h   Irwin, Judith ^e   Mahoney, Richard ⁱ   Pezzotti, Mario ^j   Schillberg, Stefan ^g   Sparrow, Penny ^e   Stoger, Eva ^h   Twyman, Richard M ^k  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CSIR Bio/Chemtek   (South Africa)

^c MAX PLANCK INSTITUTE OF MOLECULAR PLANT PHYSIOLOGY   (Germany)

^d UNIVERSITY OF LLEIDA   (Spain)

^e JOHN INNES CENTRE   (United Kingdom)

^f NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^g FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ MIHR   (United Kingdom)

^j UNIVERSITY OF VERONA   (Italy)

^k UNIVERSITY OF YORK   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CYANOCOBALAMIN; ESCHERICHIA COLI ENDOTOXIN; HEPATITIS B SURFACE ANTIGEN; INTRINSIC FACTOR; LACTOFERRIN; RECOMBINANT PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRIACYLGLYCEROL LIPASE; VEGETABLE PROTEIN; VIRUS GLYCOPROTEIN;

ARABIDOPSIS; BIOSAFETY; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CROP PRODUCTION; CYANOCOBALAMIN DEFICIENCY; CYSTIC FIBROSIS; DENTAL CARIES; DIARRHEA; DRUG RESEARCH; DRUG SAFETY; FINANCIAL MANAGEMENT; GASTROINTESTINAL INFECTION; GENETICALLY MODIFIED CROP; GOOD MANUFACTURING PRACTICE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTUCE; MAIZE; NONHODGKIN LYMPHOMA; NONHUMAN; NORWALK GASTROENTERITIS VIRUS; PANCREATITIS; PATENT; PLANT GENETICS; PLANT GROWTH; POTATO; PRIORITY JOURNAL; RABIES; RABIES VIRUS; REVIEW; SPINACH; TOBACCO; TRANSGENIC PLANT;

HUMANS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC;

ARABIDOPSIS; ESCHERICHIA COLI; HEPATITIS B VIRUS; LACTUCA; MIRIDAE; NICOTIANA TABACUM; NORWALK VIRUS; RABIES VIRUS; SOLANUM TUBEROSUM; SPINACIA OLERACEA; ZEA MAYS;

EID: 23744514106     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400470     Document Type: Review

References (35)

1. Bakker H et al (2001) Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci USA 98: 2899-2904
2. Birch-Machin I, Newell CA, Hibberd JM, Gray JC (2004) Accumulation of rotavirus VP6 protein in chloroplasts of transplastomic tobacco is limited by protein stability. Plant Biotechnol J 2: 261-270
3. Bock R (2001) Transgenic chloroplasts in basic research and plant biotechnology. J Mol Biol 312: 425-438
4. Chargelegue D, Drake PM, Obregon P, Prada A, Fairweather N, Ma JK (2005) A highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants. Infect Immun (in press)
5. Chen L et al (1998) Expression and inheritance of multiple transgenes in rice plants. Nat Biotechnol 16: 1060-1064
6. Christou P, Kohli A (2005) Transformation method and transgenic plants produced thereby. US Patent No 6846970. 25 Jan, www.uspto.gov
7. CMH (2001) Macroeconomics and Health: Investing in Health for Economic Development. Geneva, Switzerland: World Health Organization
8. Daniell H (2002) Molecular strategies for gene containment in transgenic crops. Nat Biotechnol 20: 581-586
9. Drossard J (2004) Downstream processing of plant-derived recombinant therapeutic proteins. In Fischer R, Schillberg S (eds), Molecular Farming: Plant-made Pharmaceuticals and Technical Proteins, pp 217-232. Weinheim, Germany: Wiley VCH
10. EMEA (2002) Points to Consider on Quality Aspects of Medicinal Products Containing Active Substances Produced by Stable Transgene Expression in Higher Plants (CPMP/BWP/764/02) [Draft]. London, UK: European Agency for the Evaluation of Medicinal Products
11. FDA (2002) Guidance for Industry: Drugs, Biologics, and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals [Draft Guidance]. Rockville, MD, USA: United States Food and Drug Administration
12. Fu X, Duc LT, Fontana S, Bong BB, Tinjuangjun P, Sudhakar D, Twyman RM, Christou P, Kohli A (2000) Linear transgene constructs lacking vector backbone sequences generate low-copy-number transgenic plants with simple integration patterns. Transgenic Res 9: 11-19
13. GMA (2003) GMA Comments on USDA BioPharma Permit Regulations. Field Testing of Plants Engineered to Produce Pharmaceutical and Industrial Compounds. Docket 03-031-1. 3 Oct, www.gmabrands.com
14. Harper BK, Mabon SA, Leffel SM, Halfhill MD, Richards HA, Moyer KA, Stewart CN Jr (1999) Green fluorescent protein as a marker for expression of a second gene in transgenic plants. Nat Biotechnol 17: 1125-1129
15. Loc NT, Tinjuangjun P, Gatehouse AM, Christou P, Gatehouse JA (2002) Linear transgene constructs lacking vector backbone sequences generate transgenic rice plants which accumulate higher levels of proteins conferring insect resistance. Mol Breeding 9: 231-244
16. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, LehnerT (1998) Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 4: 601-606
17. Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4: 794-805
18. Magee AM, Coyne S, Murphy D, Horvath EM, Medgyesy P, Kavanagh TA (2004) T7 RNA polymerase-directed expression of an antibody fragment transgene in plastids causes a semilethal pale-green seedling phenotype. Transgenic Res 13: 325-337
19. Mahoney RT (ed) (2004) Handbook of Best Practices for Management of Intellectual Property in Health Research and Development. Oxford, UK: Centre for the Management of Intellectual Property in Health Research and Development (MIHR)
20. Mascia PN, Flavell RB (2004) Safe and acceptable strategies for producing foreign molecules in plants. Curr Opin Plant Biol 7: 189-195
21. Menkhaus TJ, Bai Y, Zhang C, Nikolov ZL, Glatz CE (2004) Considerations for the recovery of recombinant proteins from plants. Biotechnol Prog 20: 1001-1014
22. Nicholson L, Gonzalez-Melendi P, van Dolleweerd C, Tuck H, Perrin Y, Ma JK, Fischer R, Christou P, Stoger E (2005) A recombinant multimeric immunoglobulin expressed in rice shows assembly-dependent subcellular localization in endosperm cells. Plant Biotechnol J 3: 115-127
23. Richter LJ, Thanavala Y, Arntzen CJ, Mason HS (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18: 1167-1171
24. Shattock RJ, Moore JP (2003) Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1: 25-34
25. Sijmons PC, Dekker BM, Schrammeijer B, Verwoerd TC, van den Elzen PJ, Hoekema A (1990) Production of correctly processed human serum albumin in transgenic plants. Biotechnology (NY) 8: 217-221
26. Smyth S, Phillips PWB (2002) Production differentiation alternatives: identity preservation, segregation, and traceability. AgBioForum 5: 30-42
27. Stoger E, Sack M, Perrin Y, Vaquero C, Torres E, Twyman RM, Christou P, Fischer R (2002) Practical considerations for pharmaceutical antibody production in different crop systems. Mol Breeding 9: 149-158
28. Strasser R, Altmann F, Mach L, Glossl J, Steinkellner H (2004) Generation of Arabidopsis thaliana plants with complex N-glycans lacking β1,2-linked xylose and core α1,3-linked fucose. FEBS Lett 561: 132-136
29. Sweetman JP, Chu C, Qu N, Greenland AJ, Sonnewald U, Jepson I (2002) Ethanol vapor is an efficient inducer of the alc gene expression system in model and crop plant species. Plant Physiol 129: 943-948
30. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial-antigen delivered in transgenic potato. Nature Med 4: 607-609
31. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182: 302-305
32. Tregoning R et al (2003) Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res 31: 1174-1179
33. Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21: 570-578
34. Twyman RM, Schillberg S, Fischer R (2005) Transgenic plants in the biopharmaceutical market. Expert Opin Emerg Drugs 10: 185-218
35. Yusibov V et al (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20: 3155-3164